1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Products and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Drivers 6.1.1 Paradigm Shift in Healthcare from Disease Diagnosis to Risk Assessment or Early Diagnosis 6.1.2 Increasing Usage of Biomarkers in Drug Development 6.2 Restraints 6.2.1 High Cost of Diagnosis 6.2.2 Reimbursement Issues 6.2.3 Need for Immediate Processing 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Disease 7.1.1 Prostate Cancer 7.1.2 Breast Cancer 7.1.3 Lung Cancer 7.1.4 Colorectal Cancer 7.1.5 Cervical Cancer 7.1.6 Others 7.2 By Application 7.2.1 Risk Assesment 7.2.2 Prognostics 7.2.3 Disease Diagnosis 7.2.4 Drug Discovery and Development 7.3 By Services 7.3.1 Sample Preparation 7.3.2 Assay Development 7.3.3 Biomarkers and Testing 7.4 By Type 7.4.1 Protein Biomarkers 7.4.2 Genetic Biomarkers 7.4.3 Others 7.5 By Profiling Technologies 7.5.1 OMICS Technologies 7.5.2 Imaging Technologies 7.5.3 Immunoassays 7.5.4 Cytogenetics 7.5.5 Bioinformatics 7.6 By Geography 7.6.1 Asia-Pacific 7.6.1.1 China 7.6.1.2 Japan 7.6.1.3 India 7.6.1.4 Australia & New Zealand 7.6.1.5 South Korea 7.6.1.6 Rest of Asia-Pacific 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Abbott Laboratories Inc. 9.2 Affymetrix Inc. (Thermo Fisher Scientific) 9.3 Agilent Technologies 9.4 Biomerieux 9.5 Celera Corporation (Quest Diagnostics) 9.6 Hologic, Inc. 9.7 Illumina, Inc. 9.8 Roche Holding AG *List not Exhaustive 10. Future of the Market 11. Disclaimer

Abbott Laboratories, Affymetrix Inc., (Thermo Fisher Scientific), Agilent Technologies, Hologic Inc., Roche Holding AG, Biomerieux, Celera Corporation (Quest Diagnostics), and Illumina Inc.